2Rodriguez JC, Ruiz M, Lopez M, et al. In vitro activity of moxifloxacin,levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis[J]. Int J Antimicro Agents ,2002,20(6) :464-7.
3Behra-Miellet J ,Dubreuil L,Jumas-Bilak E. Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciproflocaxin, clidamycin, metronidazole and beta-lactams[J ]. Int J Antimicrob Agents, 2002,20(5) : 366-74.
5Lode H, Garau J. Improving care for patients with respiratory tract infections[J] . J Chemother ,2002,14 ( Suppl 2):22-8.
6Breilh D,Jougon J,Djabarouti S,et al.Diffusion of oral and intravenous 400 mg once-daily moxifloxacin into lung tissue at pharmacokinetic steady-state[J].J Chemother,2003,15:558-562.
7Torres A,Muir JF,Corris P,et al.Effectiveness of oral mo-xifloxacin in standard first-line therapy in community-acquired pneumonia[J].Eur Respir J,2003,21:135-143.
8Finch R,Schurmann D,Collins O,et al.Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v.and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatment[J].Antimicrob Agents Chemother,2002,46:1746-1754.
9Starakis I,Gogos CA,Bassaris H.Five-day moxifloxacin th-erapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis[J].Int J Antimicrob Agents,2004,23:129-137.
10Grassi C,Casali L,Curti E,et al.Efficacy and safety of short course (5-day) moxifloxacin vs 7-day ceftriaxone in the treatment of acute exacerbations of chronic bronchitis[J].J Chemother,2002,14:597-608.
